Back
Phathom Pharmaceuticals Stock Predictions
Crowdfunding to IPO: Nasdaq's Next Breakout?
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
13
PHAT
Phathom Pharmaceuticals
Last Price:
$4.79
Seasonality Move:
17.73%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Phathom Pharmaceuticals Stock Forecast
-
Is Phathom Pharmaceuticals Stock Undervalued?The current Phathom Pharmaceuticals [PHAT] share price is $4.87. The Score for PHAT is 13, which is 74% below its historic median score of 50, and infers higher risk than normal.
-
PHAT is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
Will Phathom Pharmaceuticals Stock Go Up Next Year?
Data Unavailable
Phathom Pharmaceuticals Stock Rating
Data Unavailable
Phathom Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
phathompharma.com
52-Week Data
52-Week High:
19.71
52-Week Low:
4.07
Prediction Charts
Market Cap:
338.4M
Price in USD:
4.87
Volume:
792K
Beta:
0.51
Technical Analysis
SMA50:
5.76
SMA100:
7.21
SMA200:
10.80
52-Wk Change:
-55.85%
Stock Predictions
-
Is Phathom Pharmaceuticals stock public?Yes, Phathom Pharmaceuticals is a publicly traded company.
-
What is the Phathom Pharmaceuticals stock quote today?The Phathom Pharmaceuticals stock price is 4.87 USD today.
-
How to buy Phathom Pharmaceuticals stock online?You can buy Phathom Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-19 | 5.68 | 6.08 | 6.16 | 5.47 |
| Mar-20 | 6.01 | 6.26 | 6.31 | 5.92 |
| Mar-21 | 6.14 | 6.23 | 6.54 | 6.06 |
| Mar-24 | 6.26 | 6.55 | 6.61 | 6.13 |
| Mar-25 | 6.52 | 6.39 | 6.52 | 6.16 |
| Mar-26 | 6.38 | 6.42 | 6.51 | 6.03 |
| Mar-27 | 6.40 | 6.69 | 6.74 | 6.34 |
| Mar-28 | 6.69 | 6.60 | 6.89 | 6.35 |
| Mar-31 | 6.51 | 6.27 | 6.66 | 6.16 |
| Apr-1 | 5.84 | 5.12 | 5.91 | 4.76 |
| Apr-2 | 4.98 | 5.49 | 6.26 | 4.96 |
| Apr-3 | 5.23 | 5.01 | 5.48 | 4.87 |
| Apr-4 | 4.91 | 4.88 | 5.05 | 4.73 |
| Apr-7 | 4.55 | 4.87 | 5.09 | 4.42 |
Phathom Pharmaceuticals Earnings
Data Unavailable
Phathom Pharmaceuticals Forecast Revenue Growth
Data Unavailable
-
Analysts estimate an earnings increase this quarter of $0.50 per share, an increase next quarter of $0.22 per share, an increase this year of $0.78 per share, and an increase next year of $2.19 per share.
* Phathom Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.